硒蛋白P1(SEPP1)等多因子檢測試劑盒(流式熒光發(fā)光法)
Multiplex Assay Kit for Selenoprotein P1, Plasma (SEPP1) ,etc. by FLIA (Flow Luminescence Immunoassay)
SEPP; SeP; SEP-P1; SELP
(注:單次混測多因子不超過8個指標(biāo) )
- 編號LMB809Hu
 - 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
 - 實(shí)驗方法雙抗夾心
 - 反應(yīng)時長3.5h
 - 檢測范圍0.05-50ng/mL
 - 靈敏度最小可檢測劑量小于等于0.017 ng/mL.
 - 樣本類型serum, plasma and other biological fluids
 - 下載英文說明書 中文說明書
 - 規(guī)格8指標(biāo)數(shù)7指標(biāo)數(shù)6指標(biāo)數(shù)5指標(biāo)數(shù)4指標(biāo)數(shù)3指標(biāo)數(shù)2指標(biāo)數(shù)1指標(biāo)數(shù)
 - 價格¥ 2490¥ 2586¥ 2729¥ 2921¥ 3112¥ 3399¥ 3830¥ 4788 添加到價格計算器 計算器
 - 欲了解實(shí)際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
特異性
                        本試劑盒用于檢測硒蛋白P1(SEPP1)等多因子檢測試劑盒(流式熒光發(fā)光法),經(jīng)檢測與其它相似物質(zhì)無明顯交叉反應(yīng)。
                        由于受到技術(shù)及樣本來源的限制,不可能完成對所有相關(guān)或相似物質(zhì)交叉反應(yīng)檢測,因此本試劑盒有可能與未經(jīng)檢測的其它物質(zhì)有交叉反應(yīng)。
                    
回收率
分別于定值血清及血漿樣本中加入一定量的硒蛋白P1(SEPP1)等多因子檢測試劑盒(流式熒光發(fā)光法)(加標(biāo)樣品),重復(fù)測定并計算其均值,回收率為測定值與理論值的比率。
| 樣本 | 回收率范圍(%) | 平均回收率(%) | 
| serum(n=5) | 87-97 | 92 | 
| EDTA plasma(n=5) | 78-101 | 92 | 
| heparin plasma(n=5) | 92-105 | 96 | 
精密度
                    精密度用樣品測定值的變異系數(shù)CV表示。CV(%) = SD/mean×100 
                    批內(nèi)差:取同批次試劑盒對低、中、高值定值樣本進(jìn)行定量檢測,每份樣本連續(xù)測定20 次,分別計算不同濃度樣本的平均值及SD值。
                    批間差:選取3個不同批次的試劑盒分別對低、中、高值定值樣本進(jìn)行定量測定,每個樣本使用同一試劑盒重復(fù)測定8次,分別計算不同濃度樣本的平均值及SD值。
                    批內(nèi)差: CV<10% 
                    批間差: CV<12% 
線性
在定值血清及血漿樣本內(nèi)加入適量的硒蛋白P1(SEPP1)等多因子檢測試劑盒(流式熒光發(fā)光法),并倍比稀釋成1:2,1:4,1:8,1:16的待測樣本,線性范圍即為稀釋后樣本中硒蛋白P1(SEPP1)等多因子檢測試劑盒(流式熒光發(fā)光法)含量的測定值與理論值的比率。
| 樣本 | 1:2 | 1:4 | 1:8 | 1:16 | 
| serum(n=5) | 90-97% | 83-104% | 97-104% | 93-101% | 
| EDTA plasma(n=5) | 86-101% | 95-102% | 79-101% | 82-98% | 
| heparin plasma(n=5) | 97-104% | 96-105% | 78-101% | 86-96% | 
穩(wěn)定性
                    經(jīng)測定,試劑盒在有效期內(nèi)按推薦溫度保存,其活性降低率小于5%。
                    為減小外部因素對試劑盒破壞前后檢測值的影響,實(shí)驗室的環(huán)境條件需盡量保持一致,尤其是實(shí)驗室內(nèi)溫度、濕度及溫育條件。其次由同一實(shí)驗員來進(jìn)行操作可減少人為誤差。
                
實(shí)驗流程
1. 實(shí)驗前標(biāo)準(zhǔn)品、試劑及樣本準(zhǔn)備;
                            2. 加樣(標(biāo)準(zhǔn)品、樣本、磁珠)標(biāo)準(zhǔn)品或樣本100μL及磁珠10μL,
                                37°C酶標(biāo)板振蕩器孵育90分鐘;
                            3. 磁吸甩干,加檢測溶液A100μL,37°C酶標(biāo)板振蕩器孵育60分鐘;
                            4. 磁吸洗板3次;
                            5. 加檢測溶液B100μL,37°C振動孵育30分鐘;
                            6. 磁吸洗板3次;
                            7. 加鞘液100μL,旋渦震蕩2分鐘后讀數(shù)。
實(shí)驗原理
將硒蛋白P1(SEPP1)等多因子檢測試劑盒(流式熒光發(fā)光法)抗體包被于磁珠,制成固相載體,向微孔中分別加入標(biāo)準(zhǔn)品或標(biāo)本以及磁珠,其中的硒蛋白P1(SEPP1)等多因子檢測試劑盒(流式熒光發(fā)光法)與連接于固相載體上的抗體結(jié)合,然后加入生物素化的硒蛋白P1(SEPP1)等多因子檢測試劑盒(流式熒光發(fā)光法)抗體,將未結(jié)合的生物素化抗體洗凈后,加入PE標(biāo)記的親和素,再次徹底洗滌后即可上機(jī)讀數(shù)。MFI值和樣品中的硒蛋白P1(SEPP1)等多因子檢測試劑盒(流式熒光發(fā)光法)呈正相關(guān)。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| RPB809Hu01 | 硒蛋白P1(SEPP1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAB809Hu01 | 硒蛋白P1(SEPP1)多克隆抗體 | WB; IHC; ICC; IP. | 
| LAB809Hu81 | 硒蛋白P1(SEPP1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. | 
| LAB809Hu71 | 硒蛋白P1(SEPP1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. | 
| MAB809Hu25 | 硒蛋白P1(SEPP1)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAB809Hu22 | 硒蛋白P1(SEPP1)單克隆抗體 | WB; IHC; ICC; IP. | 
| MAB809Hu23 | 硒蛋白P1(SEPP1)單克隆抗體 | IHC | 
| MAB809Hu24 | 硒蛋白P1(SEPP1)單克隆抗體 | IHC | 
| MAB809Hu21 | 硒蛋白P1(SEPP1)單克隆抗體 | WB; ICC/IF | 
| SEB809Hu | 硒蛋白P1(SEPP1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMB809Hu | 硒蛋白P1(SEPP1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) | 
| The Journal of Clinical Endocrinology & Metabolism | Serum Selenoprotein P Levels in Patients with Type 2 Diabetes and Prediabetes: Implications for Insulin Resistance, Inflammation, and Atherosclerosis[PubMed: 21677040] | 
| Diabetes & metabolism journal | Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease[PubMed: 23439771] | 
| Journal of Pediatric Biochemistry | Trace elements, heavy metals and vitamins in Egyptian school children with iron deficiency anemia[Metapress:Source] | 
| Journal of Trace Elements in Medicine and Biology | Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto's thyroiditis and hypothyroidism[PubMed: 26854239] | 
| OBES RES CLIN PRACT/OBESITY RESEARCH & CLINICAL PRACTICE | Selenoprotein?P?is?elevated?in?individuals?with?obesity, but is not?independently?associated?withinsulin?resistance.[pubmed:27524654] | 
| Annals of Nutrition and Metabolism | Acute?Overfeeding?Does Not Alter Liver or?Adipose?Tissue-Derived?Cytokines?in?HealthyHumans.[pubmed:27832637] | 
| European?Journal?of?Nutrition | DNA?damage?and?oxidative?stress?response?to?selenium?yeast?in the?non-smoking?individuals: ashort-term?supplementation?trial?with?respect?to?GPX1?and SEPP1 polymorphism.[pubmed:26658762] | 
| South. Clin. Ist. Euras. | Evaluation of the Relationship Between Insulin Resistance and Selenoprotein P in Patients with Polycystic Ovary Syndrome[DOI: 10.14744/scie.2017.87597] | 
| Arch Endocrinol Metab | Serum selenium and selenoprotein-P levels in autoimmune thyroid dieases patients in a select center a transversal study[DOI: 10.1590/2359-3997000000309] | 
| British Journal of Nutrition | Selenium, selenoproteins and selenometabolites in mothers and babies at the time of birth[pubmed:28534447] | 
| Journal of?Trace?Elements?in Medicine and Biology | Biomarkers of selenium status and antioxidant effect in workers occupationally exposed to mercury[Pubmed:29895371] | 
| Biological &?Pharmceutical Bulletin | Comparison of Human Selenoprotein P Determinants in Serum between Our Original Methods and Commercially Available Kits[Pubmed:29709922] | 
| Diabetologia | Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus[Pubmed: 30470912] | 
| Biological Trace Element Research | Selenium Levels in Community Dwellers with Type 2 Diabetes Mellitus[Pubmed: 30725267] | 
| Advances in?Medical?Sciences | Can hepatokines be regarded as novel non-invasive serum biomarkers of intrahepatic lipid content in obese children?[Pubmed: 30921653] | 
| Acute swimming exercise, but not exposure to moderate hypoxic conditions reduces circulating selenoprotein P levels in short-term, high-fat diet-fed rats[Pubmed: 31236416] | |
| Hormones | Selenium and selenoprotein P in nonalcoholic fatty liver disease[Pubmed: 31493247] | 
| Bull Environ Contam Toxicol | Soil Selenium Concentration and Residents Daily Dietary Intake in a Selenosis Area: A Preliminary Study in Yutangba Village, Enshi City, China[Pubmed: 32909074] | 
| INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis[Pubmed: 32605214] | 
| Circulating hepassocin level in patients with stable angina is associated with fatty liver and renal function[] | |
| Nat Immunol | Selenium–GPX4 axis protects follicular helper T cells from ferroptosis[34413521] | 
| Reviews in Cardiovascular Medicine | Selenoprotein P-1 (SEPP1) as An Early Biomarker of Acute Kidney Injury in Patients Undergoing Cardiopulmonary Bypass[] | 


